Leveraging Innovation for Precision Medicine

Pipeline

Overview

Unlocking the value of first-in-class and technically challenging drug targets

Disease Focus
Oncology
Auto-immune

Mechanism
Gene location/fusion protein
Driver mutations
Target overexpression
Synthetic lethality

Clinical Impact
Address tumors with specific genetic mutations
Sensitize cancers to standard of care
Overcome resistance

Benefits
First-in-class/innovator status
Fast-track/breakthrough potential
Rapid path to patients and value

Broad and Deep Pipeline of Differentiated Assets

pipeline portfolio

pipeline portfolio

LSD1/HDAC6     PRMT5   PAD4   PD-L1

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.